F. Ajana
Impact in
- Virology top 10%
- HIV Research and Treatment
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Epidemiology 19
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Hepatitis B Virus Studies 4
-
- Antifungal resistance and susceptibility 7
- HIV/AIDS Research and Interventions 5
- Co-authors
- Y Mouton (10 shared papers)Y Gérard (3 shared papers)Didier Hober (2 shared papers)É. Senneville (8 shared papers)Christian Chidiac (3 shared papers)O. Leroy (3 shared papers)J.M. Bourez (4 shared papers)P Wattré (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (3 papers)HIV Medicine (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Journal of Infection (2 papers)Médecine et Maladies Infectieuses (9 papers)
- Partner nations
- FranceNetherlandsSpain
In The Last Decade
F. Ajana
40 papers receiving 330 citations
Peers
Comparison fields: 5 of 74
- Virology 54
- Infectious Diseases 167
- Molecular Medicine 37
- Applied Microbiology and Biotechnology 11
- Epidemiology 178
Countries citing papers authored by F. Ajana
This map shows the geographic impact of F. Ajana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ajana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ajana more than expected).
Fields of papers citing papers by F. Ajana
This network shows the impact of papers produced by F. Ajana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ajana. The network helps show where F. Ajana may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Ajana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 57 | |
| 2 | 1997 | 36 | |
| 3 | 1993 | 35 | |
| 4 | 2006 | 32 | |
| 5 | 2017 | 29 | |
| 6 | 1991 | 19 | |
| 7 | 1997 | 17 | |
| 8 | 1991 | 13 | |
| 9 | 1997 | 11 | |
| 10 | 1987 | 9 | |
| 11 | 2013 | 9 | |
| 12 | [Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia]. | 1991 | 9 |
| 13 | 2014 | 6 | |
| 14 | 1991 | 6 | |
| 15 | 2020 | 6 | |
| 16 | [Guillain-Barré syndrome with favorable outcome in a case of recent human immunodeficiency virus infection]. | 1988 | 5 |
| 17 | [ParaSight F in the diagnosis of Plasmodium falciparum malaria]. | 1998 | 5 |
| 18 | 2016 | 4 | |
| 19 | 2010 | 4 | |
| 20 | 1990 | 4 |
About F. Ajana
F. Ajana is a scholar working on Epidemiology, Infectious Diseases, Parasitology, Hepatology and Virology, having authored 44 papers that have together received 348 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), HIV/AIDS Research and Interventions (5 papers), Hepatitis C virus research (5 papers), Toxoplasma gondii Research Studies (5 papers), Hepatitis B Virus Studies (4 papers), Parasitic Infections and Diagnostics (4 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Virology (54 citations), Infectious Diseases (167 citations), Molecular Medicine (37 citations), Applied Microbiology and Biotechnology (11 citations) and Epidemiology (178 citations). F. Ajana has collaborated with scholars based in France, Netherlands and Spain. Frequent co-authors include Y Mouton, Y Gérard, Didier Hober, É. Senneville, Christian Chidiac, O. Leroy, J.M. Bourez, P Wattré, B Fortier and C. Beuscart. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, HIV Medicine, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Infection and Médecine et Maladies Infectieuses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.